Salahudeen AA, Seoane JA, Yuki K, et al. Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell reports. 2023;42(11):113355. doi:10.1016/j.celrep.2023.113355
Casillo SM, Gatesman TA, Chilukuri A, et al. An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma. Cell reports. 2023;43(1):113557. doi:10.1016/j.celrep.2023.113557
Jovanović B, Temko D, Stevens LE, et al. Heterogeneity and transcriptional drivers of triple-negative breast cancer. Cell reports. 2023;42(12):113564. doi:10.1016/j.celrep.2023.113564
Konda P, Garinet S, Van Allen EM, Viswanathan SR. Genome-guided discovery of cancer therapeutic targets. Cell reports. 2023;42(8):112978. doi:10.1016/j.celrep.2023.112978
Fu X, Pereira R, Liu CC, et al. High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer. Cell reports. 2023;42(8):112821. doi:10.1016/j.celrep.2023.112821
Matsuda S, Revandkar A, Dubash TD, et al. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell reports. 2023;42(3):112129. doi:10.1016/j.celrep.2023.112129